Bank Pictet & Cie Europe AG Sells 2,247 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Bank Pictet & Cie Europe AG cut its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 1.2% during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 188,722 shares of the medical equipment provider's stock after selling 2,247 shares during the quarter. Intuitive Surgical makes up about 2.2% of Bank Pictet & Cie Europe AG's investment portfolio, making the stock its 11th largest position. Bank Pictet & Cie Europe AG owned 0.05% of Intuitive Surgical worth $93,468,000 at the end of the most recent reporting period.

Several other institutional investors have also recently modified their holdings of ISRG. Atala Financial Inc bought a new position in Intuitive Surgical during the 4th quarter worth approximately $25,000. Hurley Capital LLC bought a new stake in shares of Intuitive Surgical in the 4th quarter worth approximately $28,000. Parvin Asset Management LLC bought a new stake in shares of Intuitive Surgical in the 4th quarter worth approximately $26,000. BankPlus Trust Department bought a new stake in shares of Intuitive Surgical in the 4th quarter worth approximately $28,000. Finally, Global Financial Private Client LLC grew its position in shares of Intuitive Surgical by 253.3% in the 1st quarter. Global Financial Private Client LLC now owns 53 shares of the medical equipment provider's stock worth $26,000 after buying an additional 38 shares during the last quarter. 83.64% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently weighed in on ISRG shares. Royal Bank of Canada cut their price objective on Intuitive Surgical from $630.00 to $605.00 and set an "outperform" rating on the stock in a research report on Wednesday, April 23rd. Citigroup reiterated a "buy" rating and issued a $650.00 price objective (up from $590.00) on shares of Intuitive Surgical in a research report on Thursday, May 22nd. BTIG Research set a $560.00 price objective on Intuitive Surgical and gave the stock a "buy" rating in a research report on Monday, April 14th. Evercore ISI cut their price objective on Intuitive Surgical from $510.00 to $470.00 and set an "in-line" rating on the stock in a research report on Wednesday, April 23rd. Finally, Truist Financial cut their price objective on Intuitive Surgical from $605.00 to $590.00 and set a "buy" rating on the stock in a research report on Wednesday, April 23rd. One equities research analyst has rated the stock with a sell rating, four have given a hold rating and fifteen have assigned a buy rating to the company. Based on data from MarketBeat.com, Intuitive Surgical presently has an average rating of "Moderate Buy" and an average target price of $588.95.

Intuitive Surgical Trading Up 1.3%

NASDAQ:ISRG traded up $6.86 during trading hours on Monday, reaching $519.04. 1,513,773 shares of the company traded hands, compared to its average volume of 1,675,177. The business's 50-day moving average price is $526.57 and its two-hundred day moving average price is $538.46. The stock has a market capitalization of $186.03 billion, a P/E ratio of 80.97, a P/E/G ratio of 5.85 and a beta of 1.67. Intuitive Surgical, Inc. has a 1 year low of $413.82 and a 1 year high of $616.00.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last announced its quarterly earnings data on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.71 by $0.10. Intuitive Surgical had a return on equity of 14.55% and a net margin of 27.81%. The business had revenue of $2.25 billion during the quarter, compared to analysts' expectations of $2.19 billion. During the same quarter in the previous year, the business earned $1.50 earnings per share. As a group, equities analysts anticipate that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

Insider Transactions at Intuitive Surgical

In related news, EVP Robert Desantis sold 188 shares of the company's stock in a transaction on Monday, April 28th. The stock was sold at an average price of $515.91, for a total transaction of $96,991.08. Following the completion of the sale, the executive vice president now owns 5,224 shares in the company, valued at approximately $2,695,113.84. This represents a 3.47% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, SVP Mark Brosius sold 216 shares of the company's stock in a transaction on Friday, June 6th. The shares were sold at an average price of $563.11, for a total value of $121,631.76. Following the sale, the senior vice president now owns 907 shares of the company's stock, valued at approximately $510,740.77. This trade represents a 19.23% decrease in their position. The disclosure for this sale can be found here. Insiders sold 4,998 shares of company stock worth $2,611,577 over the last quarter. 0.70% of the stock is currently owned by insiders.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.